Skip to main content

Table 2 MIC values for common clinical antibiotics against PAHM4 and PAO1

From: Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains

Class Antibiotic MIC μg/ml for PAO1 MIC μg/ml for HM4
Penicillins Piperacillin 4 (S) >256 (R)
  Piperacillin-Tazobactam 2 (S) >256 (R)
  Carbenicillin 32 64
Cephalosporins Ceftazidime 1 (S) 16 (I)
  Cefepime 1 (S) 6 (S)
  Cefotaxime 8 >256
  Ceftolozane 0.25 1
Monobactam Aztreonam 2 (S) 8 (S)
Carbapenems Imipenem 1.5 (S) 1.5 (S)
  Meropenem 0.38 (S) 0.19 (S)
Quinolones Ciprofloxacin 0.125 (S) 2 (I)
Aminoglycoside Amikacin 4 (S) 96 (R)
  Gentamicin 2 (S) 32 (R)
  Tobramycin 1.5 (S) 4 (S)
Polymyxin Colistin 2 (S) 0.19 (S)
Tetracycline Tetracycline 16 4
Macrolide Azithromycin 64 16
  1. Absolute MIC values and, when available, CLSI clinical categories (S: susceptible, I: intermediate, R: resistant) are indicated